Clinical Research That Move Innovation Forward.
Clinrova Develops and Implements Clinical Operations Strategies for Biotech, Diagnostics, and Life Sciences Startups That Are Ready to Raise Capital, Go Public, or Get Acquired.
Your Investors Expect a Strong Clinical Strategy. I’ll Help You Deliver It.
Most early-stage biotech and diagnostic companies struggle to clearly demonstrate clinical readiness to investors. You may have a groundbreaking product but lack the operational strategy, trial design clarity, or executional proof points to build investor confidence. Unclear protocols, weak vendor oversight, unrealistic timelines, and under-resourced plans can quietly stall your momentum.
I’m Ashley Gantt, and Clinrova is the consulting firm I created to help early-stage biotech, diagnostics, and life science companies develop sound clinical trial strategies that withstand investor scrutiny. I focus on sponsor-dependent risk, particularly clinical operations capabilities, and offer trial design support that aligns with your business goals—whether that’s a funding round, IPO, or acquisition.